Real-world data on spinal muscular atrophy in Spain: Insights from over 500 individuals in the CuidAME project
Open Access
- 28 July 2025
- journal article
- Published by SAGE Publications in Journal of Neuromuscular Diseases
- Vol. 12 (6) , 837-848
Abstract
Background: The new treatment paradigm in Spinal Muscular Atrophy (SMA) has introduced novel phenotypes, changes in trajectories and clinical questions not fully addressed in clinical trials. To explore these challenges, several international initiatives have emerged. CuidAME was created as a nationwide clinical network in Spain designed to standardise SMA care, facilitate knowledge sharing, and capture data in a longitudinal comprehensive registry. Objective: Evaluating the usefulness of the CuidAME project to capture data in a real-world setting. Methods: This multicentric cohort study includes individuals with SMA followed at participating hospitals. Clinical examinations and multidisciplinary assessments were performed during routine clinical visits. We present a cross-sectional analysis of the registry population. Results: As of February 2025, 543 participants from 25 hospitals were recruited: 12 were presymptomatic, 125 (23%) had SMA type 1, 208 (35%) type 2, 194 (38%) type 3, and 4 (CuidAME is an academic, longitudinal, real-world data collection project that demonstrated a fast and effective model for implementation facilitating the standardization of clinical practices and outcome measures across Spain. By aligning with core dataset used in other registries and establishing multidisciplinary working groups, the initiative will contribute to sharing knowledge to advance SMA care and improve patient outcomes.Keywords
This publication has 36 references indexed in Scilit:
- 2024 update: European consensus statement on gene therapy for spinal muscular atrophyEuropean Journal of Paediatric Neurology, 2024
- Clinical Effectiveness of Newborn Screening for Spinal Muscular AtrophyJAMA Pediatrics, 2024
- Validation of a Set of Instruments to Assess Patient- and Caregiver-Oriented Measurements in Spinal Muscular Atrophy: Results of the SMA-TOOL StudyNeurology and Therapy, 2022
- Physical fatigue and perceived fatigability in adolescents and adults with spinal muscular atrophy: A pilot studyNeurology Perspectives, 2022
- Design of a Non-Interventional Study to Validate a Set of Patient- and Caregiver-Oriented Measurements to Assess Health Outcomes in Spinal Muscular Atrophy (SMA-TOOL Study)Neurology and Therapy, 2021
- Correlation between SMA type and SMN2 copy number revisited: An analysis of 625 unrelated Spanish patients and a compilation of 2834 reported casesNeuromuscular Disorders, 2018
- Diagnosis and management of spinal muscular atrophy: Part 2: Pulmonary and acute care; medications, supplements and immunizations; other organ systems; and ethicsNeuromuscular Disorders, 2018
- Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional careNeuromuscular Disorders, 2018
- A multi-source approach to determine SMA incidence and research ready populationJournal of Neurology, 2017
- Identification and characterization of a spinal muscular atrophy-determining geneCell, 1995